血流储备分数或造影指导下的多支血管PCI治疗心肌梗死
这项多中心试验将STEMI合并多支病变、梗死相关动脉PCI成功的患者随机分配至FFR指导或造影指导的完全血运重建。主要终点为1年全因死亡、非致死性心肌梗死或导致紧急血运重建的非计划住院的复合终点。FFR组586例中32例(5.5%)发生主要终点事件,造影组577例中24例(4.2%)发生(HR 1.32,95%CI 0.78-2.23,P=0.31)。FFR组每例患者非罪犯病变置入支架数平均1.01±0.99枚,造影组1.50±0.86枚。作者认为FFR指导策略未显示显著获益,但置信区间宽,不能得出确定性结论。
要点
- STEMI多支病变完全血运重建:FFR指导组主要终点事件5.5%(32/586)vs 造影指导组4.2%(24/577),HR 1.32(95%CI 0.78-2.23),P=0.31,未达统计学显著。
- FFR指导组每例非罪犯病变置入支架数平均1.01±0.99枚,少于造影指导组的1.50±0.86枚。
- 全因死亡:FFR组1.5%(9例)vs 造影组1.7%(10例);非致死性心肌梗死:3.1%(18例)vs 1.7%(10例);导致紧急血运重建的非计划住院:2.6%(15例)vs 1.9%(11例)。
- 作者指出效应估计的置信区间宽, findings 不能得出确定性解释。
适用人群与场景
- STEMI合并多支病变、且梗死相关动脉已成功行PCI的患者。
处置流程与药物剂量
- 完全血运重建策略:FFR指导或造影指导,用于非罪犯病变。
研究设计与关键结果
- 多中心随机试验:STEMI合并多支病变且梗死相关动脉PCI成功者随机接受FFR指导或造影指导的完全血运重建。
- 主要终点为1年全因死亡、非致死性心肌梗死或导致紧急血运重建的非计划住院的复合终点。
- 主要终点事件:FFR指导组32/586例(5.5%)vs 造影指导组24/577例(4.2%),HR 1.32(95%CI 0.78-2.23),P=0.31。
- 全因死亡:FFR组9例(1.5%)vs 造影组10例(1.7%)。
- 非致死性心肌梗死:FFR组18例(3.1%)vs 造影组10例(1.7%)。
- 导致紧急血运重建的非计划住院:FFR组15例(2.6%)vs 造影组11例(1.9%)。
- 每例患者非罪犯病变置入支架数:FFR指导组平均1.01±0.99枚 vs 造影指导组1.50±0.86枚。
证据类型、等级与局限
- 证据类型:多中心随机对照试验(FLOWER-MI,ClinicalTrials.gov NCT02943954)。
- 作者结论:FFR指导策略在1年死亡、心肌梗死或紧急血运重建风险上未显著优于造影指导策略;但效应估计置信区间宽,不能得出确定性解释。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在STEMI合并多支病变、梗死相关动脉PCI成功的患者中,FFR指导的完全血运重建较造影指导未显著降低1年死亡、心肌梗死或紧急血运重建风险(HR 1.32,95%CI 0.78-2.23,P=0.31),作者认为因置信区间宽不能得出确定性结论。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In patients with ST-elevation myocardial infarction (STEMI) who have multivessel disease, percutaneous coronary intervention (PCI) for nonculprit lesions (complete revascularization) is superior to treatment of the culprit lesion alone. However, whether complete revascularization that is guided by fractional flow reserve (FFR) is superior to an angiography-guided procedure is unclear.
METHODS: In this multicenter trial, we randomly assigned patients with STEMI and multivessel disease who had undergone successful PCI of the infarct-related artery to receive complete revascularization guided by either FFR or angiography. The primary outcome was a composite of death from any cause, nonfatal myocardial infarction, or unplanned hospitalization leading to urgent revascularization at 1 year.
RESULTS: The mean (±SD) number of stents that were placed per patient for nonculprit lesions was 1.01±0.99 in the FFR-guided group and 1.50±0.86 in the angiography-guided group. During follow-up, a primary outcome event occurred in 32 of 586 patients (5.5%) in the FFR-guided group and in 24 of 577 patients (4.2%) in the angiography-guided group (hazard ratio, 1.32; 95% confidence interval, 0.78 to 2.23; P = 0.31). Death occurred in 9 patients (1.5%) in the FFR-guided group and in 10 (1.7%) in the angiography-guided group; nonfatal myocardial infarction in 18 (3.1%) and 10 (1.7%), respectively; and unplanned hospitalization leading to urgent revascularization in 15 (2.6%) and 11 (1.9%), respectively.
CONCLUSIONS: In patients with STEMI undergoing complete revascularization, an FFR-guided strategy did not have a significant benefit over an angiography-guided strategy with respect to the risk of death, myocardial infarction, or urgent revascularization at 1 year. However, given the wide confidence intervals for the estimate of effect, the findings do not allow for a conclusive interpretation. (Funded by the French Ministry of Health and Abbott; FLOWER-MI ClinicalTrials.gov number, NCT02943954.).
参考来源
- Puymirat E, Cayla G, Simon T, et al. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction. N Engl J Med. 2021. PMID: 33999545. doi:10.1056/NEJMoa2104650
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。